India’s pharmaceutical industry significantly increased exporting drugs when the world was suffering from the coronavirus pandemic in the first half of the current fiscal year. The country’s formulation surged 18 per cent while the bulk drug exports rose 9 per cent on-year during H1 FY21, said a report by Crisil. During the full previous fiscal, the exports of formulation rose 11 per cent and that of bulk drug contracted by 1 per cent. A spike in demand for pharma products, induced by the Covid-19 pandemic, and hoarding of supplies by some nations in the wake of production disruptions have boosted the exports, the report added.

(Financial Express)